Compare VTRS & INVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VTRS | INVH |
|---|---|---|
| Founded | 1961 | 2012 |
| Country | United States | United States |
| Employees | 30000 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2B | 16.2B |
| IPO Year | 2019 | 2016 |
| Metric | VTRS | INVH |
|---|---|---|
| Price | $13.84 | $25.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 18 |
| Target Price | $13.50 | ★ $32.44 |
| AVG Volume (30 Days) | ★ 7.6M | 6.0M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | 3.56% | ★ 4.61% |
| EPS Growth | N/A | ★ 29.73 |
| EPS | N/A | ★ 0.96 |
| Revenue | ★ $14,299,900,000.00 | $2,729,296,000.00 |
| Revenue This Year | $4.41 | $2.92 |
| Revenue Next Year | $1.96 | $2.43 |
| P/E Ratio | ★ N/A | $27.09 |
| Revenue Growth | N/A | ★ 4.21 |
| 52 Week Low | $7.34 | $24.25 |
| 52 Week High | $16.47 | $35.80 |
| Indicator | VTRS | INVH |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 56.93 |
| Support Level | $12.90 | $25.37 |
| Resistance Level | $16.38 | $27.65 |
| Average True Range (ATR) | 0.31 | 0.47 |
| MACD | 0.08 | 0.18 |
| Stochastic Oscillator | 97.35 | 81.51 |
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.